|
Category:
Description:
Indications:
Contraindications:
-
GI
bleeding, constipation, fecal impaction, GI obstruction
-
Hypophosphatemia,
renal disease
Precautions:
Adverse
Reactions (Side Effects):
-
CNS:
dementia, malaise, encephalopathy
-
GI:
bowel obstruction, constipation, hemorrhoids
-
METAB:
hypercalcemia, hypophosphatemia
-
GU:
nephrolithiasis
-
MISC:
weakness, osteomalacia, osteoporosis
|
Dosage:
Administered
orally
-
Hyperacidity (as an antacid) associated with
gastritis, peptic ulcer disease including duodenal ulcer and possibly
gastric ulcer, reflux esophagitis, and hiatal hernia:
-
Adult:
PO 40-60ml every 3-6 hours, or 1 and 3 hours after meals
and at bedtime as tablet, capsule, or suspension.
For the acute management of reflux esophagitis, doses may
be administered every hour if necessary.
The OTC recommended dose for oral suspension is 10ml taken
5-6 times daily, between meals and at bedtime.
The recommended OTC dose for Amphojel tablets is 600mg PO
5-6 times per day, between meals and at bedtime.
-
Child:
PO 5-15ml oral suspension given every 3-6 hours, or 1 and 3
hours after meals and at bedtime
-
Infant:
PO 1-2 ml/kg oral suspension given every 4 hours as needed
-
Stress gastritis prophylaxis:
-
Adult:
PO 40-60ml every 3-6 hours, or 1 and 3 hours after meals
and at bedtime. Dosage
should be titrated according to intragastric pH
-
Child:
PO 5-15ml suspension given every 1-2 hours; titrate to
gastric pH > 3.5
-
Infant:
PO 2-5ml suspension given every 1-2 hours; titrate to
gastric pH > 3.5
-
Neonate:
PO 1 ml/kg suspension given every 4 hours as needed
-
Management of hyperphosphatemia secondary to
renal osteodystrophy in patients with end stage renal disease:
-
Adult:
PO 30-40ml suspension administered with each meal or snack.
NOTE: Some clinicians prefer to avoid aluminum salts for this
indication. Although
calcium salts are preferred, aluminum salts may be desirable when
serum calcium is also high. When
the serum phosphate has been lowered sufficiently, aluminum salts
can be replaced by calcium salts.
-
Child:
PO 50-150 mg/kg/day divided in 4-6 daily doses
|
Approved for public release; Distribution is unlimited.
The listing of any non-Federal product in this CD is not an
endorsement of the product itself, but simply an acknowledgement of the source.
Operational Medicine 2001
Health Care in Military Settings
Bureau of Medicine and
Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational
Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
*This web version is provided by
The Brookside Associates Medical Education
Division. It contains original contents from the official US Navy
NAVMED P-5139, but has been reformatted for web access and includes advertising
and links that were not present in the original version. This web version has
not been approved by the Department of the Navy or the Department of Defense.
The presence of any advertising on these pages does not constitute an
endorsement of that product or service by either the US Department of Defense or
the Brookside Associates. The Brookside Associates is a private organization,
not affiliated with the United States Department of Defense.
Contact Us · · Other
Brookside Products
|